Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Itamar Raz

Showing results (71-80 of 310) with videos related to

Pageof 31
Sort By:
Diabetes Research and Clinical Practice|June 16, 2005
Early use of insulin in type 2 diabetesRoy Eldor, Erwin Stern, Zvonko Milicevic, et al.
The New England Journal of Medicine|May 9, 2019
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. ReplyStephen D Wiviott, Itamar Raz, Marc S Sabatine
Harefuah|October 24, 2021
[COMPARISON OF A RECOMMENDATION FOR A DESIRABLE HBA1C VALUE BY INTERNAL WARD PHYSICIANS, DIABETES PHYSICIANS AND AN APPLICATION, FOR DIABETES PATIENTS DISCHARGED FROM HOSPITALIZATION IN AN INTERNAL WARD]Julio Wainstein, Gregory Luzovetsky, Hedi Auerbach, et al.
The Israel Medical Association Journal : IMAJ|February 20, 2010
In anticipation of patient participationAvital Nahmias, Orly Tamir, Itamar Raz, et al.
Clinical Therapeutics|December 7, 2005
Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover studySimona Cernea, Miriam Kidron, Jay Wohlgelernter, et al.
Diabetes, Obesity & Metabolism|May 23, 2008
Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic womenAuryan Szalat, Szalat Auryan, Itamar Raz, et al.
Annals of the New York Academy of Sciences|November 30, 2006
DiaPep277 preserves endogenous insulin production by immunomodulation in type 1 diabetesDana Elias, Ann Avron, Merana Tamir, et al.
Endocrine|January 1, 2017
Continuous subcutaneous insulin infusion-an opportunity for better care but not a "magic pill"Avivit Cahn, Eytan Roitman, Genya Aharon-Hananel, et al.
International Journal of Molecular Sciences|December 23, 2023
Drug Therapies for DiabetesRoni Weinberg Sibony, Omri Segev, Saar Dor, et al.
The British Journal of Nutrition|December 17, 2011
Glucose tolerance factor extracted from yeast: oral insulin-mimetic and insulin-potentiating agent: in vivo and in vitro studiesSarah Weksler-Zangen, Tal Mizrahi, Itamar Raz, et al.
Pageof 31

Showing results (71-80 of 310) with videos related to

Sort By:
Pageof 31
Diabetes Research and Clinical Practice|June 16, 2005
Early use of insulin in type 2 diabetesRoy Eldor, Erwin Stern, Zvonko Milicevic, et al.
The New England Journal of Medicine|May 9, 2019
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. ReplyStephen D Wiviott, Itamar Raz, Marc S Sabatine
Harefuah|October 24, 2021
[COMPARISON OF A RECOMMENDATION FOR A DESIRABLE HBA1C VALUE BY INTERNAL WARD PHYSICIANS, DIABETES PHYSICIANS AND AN APPLICATION, FOR DIABETES PATIENTS DISCHARGED FROM HOSPITALIZATION IN AN INTERNAL WARD]Julio Wainstein, Gregory Luzovetsky, Hedi Auerbach, et al.
The Israel Medical Association Journal : IMAJ|February 20, 2010
In anticipation of patient participationAvital Nahmias, Orly Tamir, Itamar Raz, et al.
Clinical Therapeutics|December 7, 2005
Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover studySimona Cernea, Miriam Kidron, Jay Wohlgelernter, et al.
Diabetes, Obesity & Metabolism|May 23, 2008
Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic womenAuryan Szalat, Szalat Auryan, Itamar Raz, et al.
Annals of the New York Academy of Sciences|November 30, 2006
DiaPep277 preserves endogenous insulin production by immunomodulation in type 1 diabetesDana Elias, Ann Avron, Merana Tamir, et al.
Endocrine|January 1, 2017
Continuous subcutaneous insulin infusion-an opportunity for better care but not a "magic pill"Avivit Cahn, Eytan Roitman, Genya Aharon-Hananel, et al.
International Journal of Molecular Sciences|December 23, 2023
Drug Therapies for DiabetesRoni Weinberg Sibony, Omri Segev, Saar Dor, et al.
The British Journal of Nutrition|December 17, 2011
Glucose tolerance factor extracted from yeast: oral insulin-mimetic and insulin-potentiating agent: in vivo and in vitro studiesSarah Weksler-Zangen, Tal Mizrahi, Itamar Raz, et al.
Pageof 31